Isolation of PD-L1 Extracellular Vesicle Subpopulations Using DNA Computation Mediated Microfluidic Tandem Separation

01 September 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Accurate isolation of targeted extracellular vesicle (EV) is challenging due to the heterogeneity of EV subpopulations which are from different cell origins. Most EV subpopulations lack a single marker whose expression cleanly distinguish them from mixed populations of closely related EVs. Herein, we developed a modular platform capable of taking multiple binding events as input, logic computations, and producing two independent outputs for tandem microchips for EV subpopulation isolation. Taking advantages of the excellent selectivity of dual-aptamer recognition-mediated DNA computation and the sensitivity of tandem microchips, this method achieves, for the first time, sequential isolation of tumour PD-L1 EVs and non-tumour PD-L1 EVs. As a result, the developed platform can not only effectively distinguish cancer patients from healthy donors, but also provides new clues for assessing immune heterogeneity. Moreover, the captured EVs can be released through a DNA hydrolysis reaction with high efficiency, which is compatible with downstream mass spectrometry for EV proteome profiling. Overall, this strategy is expected to isolate different EV subpopulations, translate EVs into reliable clinical biomarkers, and accurately investigate the biological functions of different EV subsets.

Keywords

Aptamer
EVs
Immunotherapy
Proximity ligation assay

Supplementary materials

Title
Description
Actions
Title
SI
Description
Supplementary Materials and Data
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.